Clinical trials in Summit, NJ

8 recruiting studies have a site in or near Summit, NJ, New Jersey.

Top conditions here

All conditions

Showing 8 of 8 studies

RecruitingPhase 3NCT07174336

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Sponsor: Eli Lilly and Company

Cherry Hill, NJ · Sewell, NJ · Summit, NJ · +126 more sites

RecruitingPhase 3NCT06997497

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Sponsor: Merck Sharp & Dohme LLC

Hackensack, NJ · Summit, NJ · +46 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Camden, NJ · Cherry Hill, NJ · Elizabeth, NJ · +1223 more sites

RecruitingPhase 1 / Phase 2NCT06733935

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Sponsor: Nkarta, Inc.

Hackensack, NJ · Summit, NJ · +14 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Camden, NJ · Cherry Hill, NJ · Elizabeth, NJ · +825 more sites

RecruitingPhase 1 / Phase 2NCT06557265

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Sponsor: Nkarta, Inc.

Summit, NJ · +16 more sites

RecruitingPhase 3NCT04852887

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Sponsor: NRG Oncology

Basking Ridge, NJ · Middletown, NJ · Montvale, NJ · +809 more sites

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Cherry Hill, NJ · Englewood, NJ · Moorestown, NJ · +952 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.